Immunogenicity and safety of two quadrivalent influenza vaccines in healthy adult and elderly participants in India - A phase III, active-controlled, randomized clinical study.

MLA

Basu, Indraneel, et al. “Immunogenicity and Safety of Two Quadrivalent Influenza Vaccines in Healthy Adult and Elderly Participants in India - A Phase III, Active-Controlled, Randomized Clinical Study.” Human Vaccines & Immunotherapeutics, vol. 18, no. 1, Jan. 2022, pp. 1–10. EBSCOhost, https://doi.org/10.1080/21645515.2021.1885278.

APA

Basu, I., Agarwal, M., Shah, V., Shukla, V., Naik, S., Supe, P. D., Srivastava, M. K., Giriraja, K. V., Pinjar, P., Mishra, P. K., Joshi, S., Vijayakumar, R., & van de Witte, S. (2022). Immunogenicity and safety of two quadrivalent influenza vaccines in healthy adult and elderly participants in India - A phase III, active-controlled, randomized clinical study. Human Vaccines & Immunotherapeutics, 18(1), 1–10. https://doi.org/10.1080/21645515.2021.1885278

Chicago

Basu, Indraneel, Manish Agarwal, Viral Shah, Vijay Shukla, Sunil Naik, Pravin Dinkar Supe, Manoj Kumar Srivastava, et al. 2022. “Immunogenicity and Safety of Two Quadrivalent Influenza Vaccines in Healthy Adult and Elderly Participants in India - A Phase III, Active-Controlled, Randomized Clinical Study.” Human Vaccines & Immunotherapeutics 18 (1): 1–10. doi:10.1080/21645515.2021.1885278.